Cross-sectional study identifies barriers to digital health technology use among pharmacists, suggesting systemic policy changes are needed.
Background: Despite growing awareness and partial utilisation of digital health technologies (DHTs) among pharmacists in Nigerian settings, adoption remains constrained by multiple barriers. Identifying and quantifying these barriers in a localised context is essential for designing effective, context-specific interventions. Objective: To identify and characterise the barriers to the adoption of digital health technologies among hospital and community pharmacists practising in Yenagoa, Bayelsa State, Nigeria. Methods: A descriptive cross-sectional study was conducted among 161 licensed practising pharmacists in Yenagoa. Barriers to DHT adoption were assessed using a nine-item instrument rated on a four-point scale (1 = not a barrier to 4 = major barrier). Descriptive statistics were used to summarise findings, reported as frequencies and percentages of respondents rating each item as a moderate or major barrier. Results: The most frequently cited barriers at the moderate-to-major level were lack of government policy or guidelines (84.5%), poor availability of digital devices (77.6%), and cost of digital tools (78.3%). Limited technical support (73.9%), lack of management support (73.9%), poor internet connectivity (72.0%), and lack of training (69.6%) were also commonly reported. High workload and time constraints (65.2%) and resistance to change (60.2%) were cited at lower but still substantial rates. The dominant barrier profile was systemic and infrastructural rather than individual or attitudinal. Conclusion: Barriers to DHT adoption among pharmacists in Yenagoa are predominantly systemic, external, and policy-level in nature, rather than stemming primarily from individual resistance or lack of motivation. Effective strategies must address the enabling environment — through policy development, infrastructure investment, and institutional support — alongside individual capacity building. Coordinated action by government, professional bodies, and healthcare institutions is essential.
No takes yet. Share an insight, caveat, or question.
Ibegi Ibegi Saviour1, Timi Fiekumo Buseri2, Peter Pereotubo Akpe, Prisca Seimiegha Levi – Owonaro3, Olodiama Providencia Chichi, Henry Messiah TMT, Owonaro A. Peter* (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: